blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4006153

EP4006153 - ENHANCED IMMUNE CELLS USING DUAL SHRNA AND COMPOSITION INCLUDING THE SAME [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  31.05.2024
Database last updated on 11.11.2024
FormerGrant of patent is intended
Status updated on  24.01.2024
FormerExamination is in progress
Status updated on  27.01.2023
FormerRequest for examination was made
Status updated on  02.12.2022
FormerThe application has been published
Status updated on  29.04.2022
Most recent event   Tooltip24.07.2024Change - representative 
Applicant(s)For all designated states
Curocell Inc.
11, Gukjegwahak 16-ro
Yuseong-gu
Daejeon, 34002 / KR
For all designated states
Korea Advanced Institute of Science and Technology
291 Daehak-ro
Guseong-dong, Yuseong-gu
Daejeon 34141 / KR
[2024/27]
Former [2022/22]For all designated states
Curocell Inc.
3rd floor, KHE Building
48 Yuseong-daero 1184 beon-gil
Yuseong-gu
Daejeon 34050 / KR
For all designated states
Korea Advanced Institute of Science and Technology
291 Daehak-ro
Guseong-dong, Yuseong-gu
Daejeon 34141 / KR
Inventor(s)01 / KIM, Chan Hyuk
34141 Daejeon / KR
02 / LEE, Young-Ho
34189 Daejeon / KR
03 / LEE, Yujean
34070 Daejeon / KR
04 / LEE, HyeongJi
34168 Daejeon / KR
05 / LEE, Sang Hoon
34116 Daejeon / KR
 [2022/22]
Representative(s)Reddie & Grose LLP
The White Chapel Building
10 Whitechapel High Street
London E1 8QS / GB
[N/P]
Former [2024/27]Carridge, Andrew Edward
Reddie & Grose LLP The White Chapel Building
10 Whitechapel High Street
London E1 8QS / GB
Former [2022/22]Jones Day
Rechtsanwälte, Attorneys-at-Law, Patentanwälte
Prinzregentenstrasse 11
80538 München / DE
Application number, filing date21207719.210.01.2019
[2022/22]
Priority number, dateKR2018000423812.01.2018         Original published format: KR 20180004238
[2022/22]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP4006153
Date:01.06.2022
Language:EN
[2022/22]
Type: B1 Patent specification 
No.:EP4006153
Date:03.07.2024
Language:EN
[2024/27]
Search report(s)(Supplementary) European search report - dispatched on:EP03.05.2022
ClassificationIPC:C12N15/113
[2022/22]
CPC:
C12N15/113 (EP,KR); C12N15/63 (KR); A61K2239/31 (EP,KR,US);
A61K2239/48 (EP,KR,US); A61K31/7088 (US); A61K38/177 (EP,US);
A61K38/1774 (US); A61K39/3955 (US); A61K39/4611 (EP,KR,US);
A61K39/4631 (EP,KR,US); A61K39/4636 (EP,KR,US); A61K39/464412 (EP,KR,US);
A61P35/00 (EP,US); C07K14/4702 (US); C07K14/7051 (EP,KR,US);
C07K14/70521 (US); C07K14/70578 (US); C07K16/2803 (EP,US);
C07K16/2809 (EP); C07K16/2818 (EP); C07K16/30 (KR);
C12N15/1075 (EP); C12N15/1138 (EP,US); C12N5/0636 (EP,KR,US);
C12N5/0637 (EP,KR,US); C12N5/0646 (EP,KR,US); A61K2039/505 (US);
C07K2317/31 (EP); C07K2317/53 (US); C07K2317/622 (EP,KR,US);
C07K2317/70 (EP); C07K2317/73 (EP); C07K2319/00 (EP);
C07K2319/02 (US); C07K2319/03 (EP,KR,US); C07K2319/30 (US);
C07K2319/33 (EP,US); C07K2319/715 (US); C12N2310/122 (US);
C12N2310/14 (EP,US); C12N2310/531 (US); C12N2320/31 (EP,US);
C12N2320/32 (US); C12N2330/51 (EP); C12N2510/00 (KR,US);
C12Q2525/301 (KR) (-)
C-Set:
C12N15/1075, C12Q2525/207 (EP);
C12N2310/531, C12N2310/14 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/01]  
Former [2022/22]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:VERBESSERTE IMMUNZELLEN UNTER VERWENDUNG VON DUALER SHRNA UND ZUSAMMENSETZUNG DAMIT[2022/22]
English:ENHANCED IMMUNE CELLS USING DUAL SHRNA AND COMPOSITION INCLUDING THE SAME[2022/22]
French:CELLULES IMMUNITAIRES AMÉLIORÉES UTILISANT UN ARNSH DOUBLE ET COMPOSITION LES COMPRENANT[2022/22]
Examination procedure01.12.2022Amendment by applicant (claims and/or description)
01.12.2022Examination requested  [2023/01]
01.12.2022Date on which the examining division has become responsible
26.01.2023Despatch of a communication from the examining division (Time limit: M06)
04.08.2023Reply to a communication from the examining division
22.08.2023Despatch of a communication from the examining division (Time limit: M04)
19.12.2023Reply to a communication from the examining division
25.01.2024Communication of intention to grant the patent
24.05.2024Fee for grant paid
24.05.2024Fee for publishing/printing paid
24.05.2024Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP19738866.3  / EP3737765
Fees paidRenewal fee
11.11.2021Renewal fee patent year 03
11.11.2021Renewal fee patent year 04
11.01.2023Renewal fee patent year 05
04.01.2024Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]US2007036773  (COOPER LAURENCE [US], et al);
 [A]WO2017040945  (MEMORIAL SLOAN KETTERING CANCER CENTER [US]);
 [X]US2017356010  (FROST GREGORY IAN [US], et al);
 [XP]WO2018049471  (BENITEC BIOPHARMA LTD [AU]);
 [XP]WO2018156886  (UNIV NEBRASKA [US])
ExaminationWO2015142675
 WO2016126608
 US2016311917
 WO2017158019
by applicantUS4690915
 US5858358
 US5883223
 US6352694
 US6534055
 US6692964
 US6797514
 US6867041
 US6887466
 US6905680
 US6905681
 US6905874
 US2006121005
 US7067318
 US7144575
 US7172869
 US7175843
 US7232566
 WO2015090230
 US9169483
 US9181544
 WO2015179525
 WO2016069282
 KR20180004238
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.